Adam Logal
Director of Finance/CFO bij OPKO HEALTH, INC.
Vermogen: 179 164 $ op 29-02-2024
Profiel
Adam E.
Logal is Chairman for Xenetic Biosciences, Inc. and CFO, Treasurer, Chief Accounting Officer & SVP at OPKO Health, Inc. Mr. Logal is also on the board of Bio-Reference Laboratories, Inc. and OPKO Biologics Ltd.
In the past Mr. Logal occupied the position of Chief Financial & Accounting Officer for Nabi Biopharmaceuticals and Finance Director, Secretary, Treasurer & CAO at eXegenics, Inc.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
OPKO HEALTH, INC.
0.03% | 29-02-2024 | 179 164 ( 0.03% ) | 179 164 $ | 29-02-2024 |
06-12-2023 | 0 ( -.--% ) | - $ | 29-02-2024 |
Actieve functies van Adam Logal
Bedrijven | Functie | Begin |
---|---|---|
OPKO HEALTH, INC. | Director of Finance/CFO | 31-03-2014 |
BIO-REFERENCE LABORATORIES INC | Director/Board Member | 20-08-2015 |
XENETIC BIOSCIENCES, INC. | Chairman | 14-08-2017 |
OPKO Biologics Ltd.
OPKO Biologics Ltd. Pharmaceuticals: MajorHealth Technology OPKO Biologics Ltd. develops next-generation, bio-better, long-acting versions of therapeutic proteins and peptide drugs. Its products include Human Growth Hormone, Glucagon dual receptor agonist, Factor VIIa and Factor IX for Hemophilia, Anti-Obesity Peptide Oxyntomodulin, Interferon and Erythropoietin, and Atherosclerosis and Rheumatoid Arthritis long-acting therapies. The company was founded by Novik A. Shai on August 22, 2003 and is headquartered in Nes Ziona, Israel. | Director/Board Member | 01-04-2014 |
Eerdere bekende functies van Adam Logal
Bedrijven | Functie | Einde |
---|---|---|
VBI VACCINES INC. | Director/Board Member | 01-10-2018 |
eXegenics, Inc. | Director of Finance/CFO | 13-06-2007 |
Nabi Biopharmaceuticals
Nabi Biopharmaceuticals BiotechnologyHealth Technology Nabi Biopharmaceuticals develops and manufactures biopharmaceutical products. It focuses on the development of vaccines addressing unmet medical needs, including gram-positive bacterial infections and nicotine addiction. The Nicotine Addiction area develops NicVAX, which is an innovative and proprietary investigational vaccine for the treatment of nicotine addiction and prevention of smoking relapse based on patented technology. Nabi Biopharmaceuticals was founded in 1969 and is headquartered in Rockville, MD. | Director of Finance/CFO | 01-01-2007 |
SciVac Therapeutics, Inc. | Director/Board Member | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 3 |
---|---|
OPKO HEALTH, INC. | Health Services |
XENETIC BIOSCIENCES, INC. | Health Technology |
VBI VACCINES INC. | Health Technology |
Bedrijven in privébezit | 5 |
---|---|
Bio-Reference Laboratories, Inc.
Bio-Reference Laboratories, Inc. Medical/Nursing ServicesHealth Services Bio-Reference Laboratories, Inc. engages in the provision testing and related services to physicians, clinics, hospitals, long-term care facilities, employers, government units, and correctional institutions. It offers a list of chemical diagnostic tests, including blood and urine analysis, blood chemistry, hematology, services, serology, radio-immuno analysis, toxicology, pap smears, tissue pathology and other tissue analysis. The firm focuses on esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health, and correctional health care. The company was founded by Marc D. Grodman in 1981 and is headquartered in Elmwood Park, NJ. | Health Services |
Nabi Biopharmaceuticals
Nabi Biopharmaceuticals BiotechnologyHealth Technology Nabi Biopharmaceuticals develops and manufactures biopharmaceutical products. It focuses on the development of vaccines addressing unmet medical needs, including gram-positive bacterial infections and nicotine addiction. The Nicotine Addiction area develops NicVAX, which is an innovative and proprietary investigational vaccine for the treatment of nicotine addiction and prevention of smoking relapse based on patented technology. Nabi Biopharmaceuticals was founded in 1969 and is headquartered in Rockville, MD. | Health Technology |
eXegenics, Inc. | Health Technology |
OPKO Biologics Ltd.
OPKO Biologics Ltd. Pharmaceuticals: MajorHealth Technology OPKO Biologics Ltd. develops next-generation, bio-better, long-acting versions of therapeutic proteins and peptide drugs. Its products include Human Growth Hormone, Glucagon dual receptor agonist, Factor VIIa and Factor IX for Hemophilia, Anti-Obesity Peptide Oxyntomodulin, Interferon and Erythropoietin, and Atherosclerosis and Rheumatoid Arthritis long-acting therapies. The company was founded by Novik A. Shai on August 22, 2003 and is headquartered in Nes Ziona, Israel. | Health Technology |
SciVac Therapeutics, Inc. | Health Technology |